U.S. Markets close in 6 hrs 9 mins

Atlas-backed Kymera signs deal with Vertex worth up to $1B

Allison DeAngelis
Atlas-backed Kymera signs deal with Vertex worth up to $1B

Cambridge startup Kymera Therapeutics just earned $70 million and could get up to $1 billion after signing a four-year collaboration deal with Vertex Pharmaceuticals.